US approval for OTC use of Bayer’s Astepro
Approval makes Astepro the first and only OTC steroid free antihistamine nasal spray available in the US
Read More
Tag: Allergy
Palforzia becomes first peanut allergy drug to get US approval
The approval marks a “defining moment” for the peanut allergy community.
Read More
Peanut allergy vaccine shows promise
There are currently no approved immunotherapies for the treatment of peanut allergies.
Read More
Positive Phase I results for Allergy’s Acarovac
Good news for patients with house dust mite-induced allergic rhinoconjunctivitis.
Read More
Circassia abandons allergy programme after trial failure
British biotech Circassia has announced the death of its allergy programme following a second key trial failure, choosing to focus all of its efforts on its respiratory business instead.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
